STUDY OF INTERRELATIONS BETWEEN RESISTANCE TO CISPLATIN AND COMPOSITION OF LOW MOLECULAR WEIGHT THIOLS IN MURINE LEUKEMIA L1210 CELL LINES

H. Falfushynska, Y. Filyak, O. Stoliar, R. Stoika


DOI: http://dx.doi.org/10.30970/sbi.0603.251

Abstract


Cis-dichlorodiammineplatinum (II), commonly known as cisplatin, is a widely used anticancer drug. However, the therapeutic efficacy of the drug is limited due to various dose-limiting side effects and development of acquired resistance. The resistance of malignant cells to cisplatin may be connected to elevated concentration of cellular thiols. To verify this hypotheses, we compared the concentrations of low weight cellular thiols, metallothionein (MT) and glutathione (reduced, GSH and oxidized, GSSG) and also the metal-binding properties of MT in the two cell lines, known to be resistant (L1210R) or sensitive (L1210S) to cisplatin. It was established that R-cells were characterised by hi­gher concentrations of MTs and GSH, higher ratio of copper in the composition of MTs in comparison to zinc than S-cells. The treatment by cisplatin provoked the decrease of the GSSG concentration only in the S-cells without the changes in GSH concentration. Hence, R-cells insensitivity to cisplatin can be related to higher levels of MTs and GSH. Reported for the first time peculiar metal composition of MTs in R-cells can also give an advance to these cells by particular oxidizing properties of copper-MT. These specific characteristics of thiols in malignant cells could be useful for the indication of cisplatin resistance.


Keywords


cisplatin, resistanse, metallothionein, glutathione, copper

Full Text:

PDF

References


1. Ahn H., Lee E., Kim K. et al. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. Journ. of Urology, 1994; 151: 263.
https://doi.org/10.1016/S0022-5347(17)34929-7

2. Akiyama S., Chen Z.S., Sumizawa T. et al. Resistance to cis-diamminedichloroplatinum(II) (cisplatin), Frequently cited mechanisms include reduced accumulation, elevated levels of glutathione (GSH) and metallothionein, and enhanced DNA repair. Anticancer Drug Design, 1999; 14(2): 143-151.

3. Bay B-H., Jin R., Huang J., Tan P.-H. Metallothionein as a Prognostic Biomarker in Breast Cancer. Experimental Biology and Medicine, 2006; 231(9): 1516-1521.
https://doi.org/10.1177/153537020623100910
PMid:17018874

4. Boubakari, Bracht K., Neumann C. et al. No correlation between GSH levels in human cancer cell lines and the cell growth inhibitory activities of platinum diamine complexes. Archives of Pharmacal (Weinheim), 2004; 337(12): 668-671.
https://doi.org/10.1002/ardp.200400620
PMid:15614830

5. Chan H.M., Cherian M.G., Bremner I. Quantification of metallothionein isoforms using an enzyme-linked immunosorbent assay (ELISA) with two specific antisera. Toxicology and Applied Pharmacology, 1992; 116(2): 267-270.
https://doi.org/10.1016/0041-008X(92)90306-D

6. Chen G., Frei E., Zeller W.J. Determination of intracellular reduced glutathione and glutathione related enzyme activities in cisplatin-sensitive and resistant experimental ovarian carcinoma cell lines. Cancer Letter, 1989; 46(3): 207-211.
https://doi.org/10.1016/0304-3835(89)90132-8

7. Coyle P., Hubert C.A., Philcox J.C. et al. Importance of storage conditions for the stability of zinc- and cadmium-induced metallothionein. Biological Trace Element Research, 2001; 81(3): 269-278.
https://doi.org/10.1385/BTER:81:3:269

8. Dondero F., Cavaletto M., Ghezzi A.R. et al. Biochemical characterization and quantitative gene expression analysis of the multi-stress inducible metallothionein from Tetrahymena thermophila. Protist, 2004;155: 157-168.
https://doi.org/10.1078/143446104774199565
PMid:15305793

9. Eid H., Geczi L., Bodrogi I. et al. Do metallothioneins affect the response to treatment in testis cancers? Journ. of Cancer Research and Clinical Oncology, 1998; 124(1): 31-36.
https://doi.org/10.1007/s004320050130
PMid:9498832

10. Falfushynska H.I., Romanchuk L.D., Stoliar O.B. Reactivity of metallothioneins in frog Rana ridibunda treated by copper and zinc ions. Ukrainian Biochemical Journ, 2010; 82(3): 17-26.

11. Farnworth P., Hillcoat B., Roos I. Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells. Cancer Chemotherapy and Pharmacology, 1990; 25(6): 411-417.
https://doi.org/10.1007/BF00686051
PMid:2311168

12. Fleet J.C., Andrews G.K., McCormick C.C. Iron-induced metallothionein in chick liver: a rapid, route-dependent effect independent of zinc status. Journ. Nutrition, 1990; 120: 1214-1222.
https://doi.org/10.1093/jn/120.10.1214
PMid:2213249

13. Guevara-Ortiz J.M., Omar-Castellanos V., Leon-Chavez B.A. et al. Interferon alpha induction of metallothionein in rat liver is not linked to interleukin-1, interleukin-6, or tumor necrosis factor alpha. Experimental and Molecular Pathology, 2005; 79: 33-38.
https://doi.org/10.1016/j.yexmp.2005.02.005
PMid:16005709

14. Habeeb A.F. A sensitive method for localization of disulfide containing peptides in column effluents. Analitycal Biochemistry, 1973; 56: 60-65.
https://doi.org/10.1016/0003-2697(73)90169-3

15. Hagrman D., Goodisman J., Dabrowiak J.C. et al. Kinetic study on the reaction of cisplatin with metallothionein. Drug Metabolism and Disposition, 2003; 31(7): 916-923.
https://doi.org/10.1124/dmd.31.7.916
PMid:12814969

16. Harris E.D. Cellular copper transport and metabolism. Annual Review of Nutrition, 2000; 20: 291-310.
https://doi.org/10.1146/annurev.nutr.20.1.291
PMid:10940336

17. Hofs H.P., Wagener T.D., de Valk-Bakker V. et al. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity. Anticancer Drugs, 1997; 8(4): 349-357.
https://doi.org/10.1097/00001813-199704000-00007
PMid:9180388

18. Hrubisko M., McGown A.T., Fox B.W. The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents. Biochemical Pharmacology, 1993; 45(1): 253-256.
https://doi.org/10.1016/0006-2952(93)90399-H

19. Janssen A.M., van Duijn W., Kubben F.J. et al. Prognostic Significance of Metallothionein in Human Gastrointestinal Cancer. Clinical Cancer Research, 2002; 8: 1889-1896.

20. Kagi J.H.R., Schaffer A. Biochemistry of metallothionein. Biochemistry, 1988; 27: 8509-8515.
https://doi.org/10.1021/bi00423a001
PMid:3064814

21. Khynriam D., Prasad S.B. Changes in endogenous tissue glutathione level in relation to murine ascites tumor growth and the anticancer activity of cisplatin. Brazilian Journ. of Medical and Biological Research, 2003; 36: 53-63.
https://doi.org/10.1590/S0100-879X2003000100008
PMid:12532227

22. Klaassen C.D., Liu J., Choudhuri S. Metallothionein: An intracellular protein to protect against Cd toxicity. Annual Review of Pharmacology and Toxicology, 1999; 39: 267-294.
https://doi.org/10.1146/annurev.pharmtox.39.1.267
PMid:10331085

23. Nicolson M.C., Orr R.M., O'Neill C.F. et al. The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Neoplasma, 1992; 39(3): 189-195.

24. Okuno S., Sato H., Kuriyama-Matsumura K. et al. Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. British Journ.of Cancer, 2003; 88(6): 951-956.
https://doi.org/10.1038/sj.bjc.6600786
PMid:12644836 PMCid:PMC2377069

25. Paris-Palacios S., Biagianti-Risbourg S., Fouley A. et al. Metallothioneins in liver of Rutilus rutilus exposed to Cu2+. Analysis by metal summation, SH determination and spectrofluorimetry. Comparative Biochemistry and Physiology, 2000; 126C: 113-122.
https://doi.org/10.1016/S0742-8413(00)00103-1

26. Reeves P.G., Saari J.T. Effect of cis-diamminedichloroplatinum (II) on metallothionein induction and trace element metabolism in rats fed different amounts of dietary zinc. Journ. of Nutritional Biochemistry. 1990;1(7): 374-81.
https://doi.org/10.1016/0955-2863(90)90008-9

27. Rutherford J.C., Bird A.J. Metal-Responsive Transcription Factors That Regulate Iron, Zinc, and Copper Homeostasis in Eukaryotic Cells. Eukaryotic Cell, 2004; 3(1): 1-13.
https://doi.org/10.1128/EC.3.1.1-13.2004
PMid:14871932 PMCid:PMC329510

28. Sedlak J., Lindsay R.H. Estimation of total, protein-bound and non-protein sulphhydril groups in tissue with Ellmans reagent. Analytical Biochemistry, 1968; 25 192-205.
https://doi.org/10.1016/0003-2697(68)90092-4

29. Shimoda R., Achanzar W.E., Qu W. et al. Metallothionein Is a Potential Negative Regulator of Apoptosis. Toxicological Sciences, 2003; 73: 294-300.
https://doi.org/10.1093/toxsci/kfg095
PMid:12700406

30. Stoliar O.B., Falfushynska H.I. Metallothionein of aquatic animals as a biomarker. Coverage of vulnerability. Global Journ. of Environmental Science and Technology. Simplex Academic Publishers, 2012; 2: 5.

31. Suzuki K.T. Purification of vertebrate metallothioneins. Methods in Enzymology. Metallobiochemistry. Part B. Metallothionein and Related Molecules, 1991; 205: 252-263.
https://doi.org/10.1016/0076-6879(91)05105-5

32. Tanaka-Kagawa T., Kitahara J., Seko Y. et al. Reduced sensitivity of HeLa cells to cis-platinum by simultaneous overexpression of copper, zinc-superoxide dismutase and catalase. Biochemical Pharmacology, 1999; 57: 545-548.
https://doi.org/10.1016/S0006-2952(98)00328-1

33. Wang W., Ballatori N. Endogenous glutathione conjugates: occurance and biological functions. Pharmacological Reviews, 1998; 50: 335-355.

34. Yang Y.Y., Woo E.S., Reese C.E. et al. Human metallothionein isoform gene expression in cis-platin-sensitive and resistant cells. Molecular Pharmacology, 1994; 45: 453.

35. Yasuno T., Matsumura T., Shikata T. et al. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line. Anticancer Research, 1999; 19(5B): 4049-4057.

36. Zhang B., Tang W., Gao S., Zhou Y. Platinum binding to metallothionein. Analysis of circular dichroism spectra of complexes formed between metallothionein and platinum from cis- and trans-diamminedichloroplatinum. Journ. of Inorganic Biochemistry, 1995; 58(1): 9-19.
https://doi.org/10.1016/0162-0134(94)00031-5


Refbacks

  • There are currently no refbacks.


Copyright (c) 2012 Studia biologica

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.